Gastrointestinal Malignancies Clinical Trial
Official title:
A Study of the Role of Circulating Tumor DNA in Predicting the Likelihood of Organ Preservation After Clinical Complete Response to Neoadjuvant Therapy for Rectal Cancer
In this research study, the investigators are looking to see if the circulating tumor DNA (genetic material), also known as ctDNA, in the blood will help them predict whether the participant's cancer will come back.
In this research study, the investigator are performing blood draws to see if the presence or absence of circulating tumor DNA (ctDNA), the genetic material in the participant's cancer's cells, will help the investigators predict whether the participant's cancer will come back or not. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05229588 -
Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations
|
Phase 2 |